GSK4418959 (enantiomer)
Selected Variant
HY-169422A-01
Size: 1 mg
GSK4418959 enantiomer is an enantiomer of GSK4418959. GSK4418959 (IDE275) is a non-covalent, reversible, selective and orally active WRN helicase inhibitor. GSK4418959 inhibits ATPase and DNA unwinding functions in an ATP-competitive manner. GSK4418959 can be used for the study of microsatellite instability-high (MSI-H) cancer[1].
Product Specifications
CAS Number
3064599-37-4
Product Name Alternative
IDE275 (enantiomer)
UNSPSC
12352005
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Concentration
10mM
Purity
95.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(N(C(C)=N2)C)C2=C1)(N(C3=CC=C([C@@H]4CCC[C@@H]([C@H]4C(O)=O)C(NC5=C(F)C=C(C(F)(F)F)C=C5)=O)C=C3)C)=O
Molecular Formula
C31H30F4N4O5S
Molecular Weight
646.65
References & Citations
[1]Joshua P. Taygerly, et al. Abstract 5750: Discovery of GSK4418959 (IDE275) : A novel, non-covalent, reversible Werner Helicase inhibitor and a new potential therapeutic for the treatment of MSI-H cancers. Cancer Res (2025) 85 (8_Supplement_1) :5750.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470010-100 1x 100 µL
MART-1 / Melan-A (M2-9E3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941461-500 1x 500 µL
CD45 / LCA (B-Cell Marker) (PTPRC/1461), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880850-100 1x 100 µL
Bcl-6 (BCL6/850), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC743219-500 1x 500 µL
Glycophorin A / CD235a (Erythrocyte Marker) (GYPA/3219R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
